190 related articles for article (PubMed ID: 35658727)
1. Protein-Ligand Identification and
Lim SYM; Loo JSE; Alshagga M; Alshawsh MA; Ong CE; Pan Y
Int J Toxicol; 2022; 41(5):355-366. PubMed ID: 35658727
[TBL] [Abstract][Full Text] [Related]
2.
Lim SYM; Alshagga MA; Alshawsh MA; Ong CE; Pan Y
Drug Metab Pers Ther; 2021 Aug; 37(1):55-67. PubMed ID: 35146975
[TBL] [Abstract][Full Text] [Related]
3.
Lim SYM; Loo JSE; Alshagga M; Alshawsh MA; Ong CE; Pan Y
Toxicol Rep; 2022; 9():759-768. PubMed ID: 36518400
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
5. Effect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 Activity.
Lim SYM; Binti Azidin AR; Ung YT; Al-Shagga M; Alshawsh MA; Mohamed Z; Ong CE; Pan Y
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):423-431. PubMed ID: 30306496
[TBL] [Abstract][Full Text] [Related]
6. Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.
Bedada W; de Andrés F; Engidawork E; Hussein J; LLerena A; Aklillu E
Sci Rep; 2018 Aug; 8(1):12726. PubMed ID: 30143732
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
8. Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro.
Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
J Nat Med; 2014 Apr; 68(2):402-6. PubMed ID: 23881640
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
[TBL] [Abstract][Full Text] [Related]
10. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
Kahma H; Aurinsalo L; Neuvonen M; Katajamäki J; Paludetto MN; Viinamäki J; Launiainen T; Filppula AM; Tornio A; Niemi M; Backman JT
Eur J Pharm Sci; 2021 Jul; 162():105810. PubMed ID: 33753217
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4.
Renwick AB; Lewis DF; Fulford S; Surry D; Williams B; Worboys PD; Cai X; Wang RW; Price RJ; Lake BG; Evans DC
Xenobiotica; 2001 Apr; 31(4):187-204. PubMed ID: 11465405
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P
Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.
Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP
Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
McCormick A; Swaisland H; Reddy VP; Learoyd M; Scarfe G
Xenobiotica; 2018 Jun; 48(6):555-564. PubMed ID: 28657402
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
16. Screening of drug metabolizing enzymes for fusidic acid and its interactions with isoform-selective substrates in vitro.
Chen D; Lin XX; Zhao Q; Xiao J; Peng SF; Xiao MF; Ouyang DS; Tan ZR; Wang YC; Peng JB; Zhang W; Chen Y
Xenobiotica; 2017 Sep; 47(9):778-784. PubMed ID: 27571049
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cytochrome P450 enzymes by Bacopa monnieri standardized extract and constituents.
Ramasamy S; Kiew LV; Chung LY
Molecules; 2014 Feb; 19(2):2588-601. PubMed ID: 24566323
[TBL] [Abstract][Full Text] [Related]
19. Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng.
Xiao J; Chen D; Lin XX; Peng SF; Xiao MF; Huang WH; Wang YC; Peng JB; Zhang W; Ouyang DS; Chen Y
PLoS One; 2016; 11(2):e0147183. PubMed ID: 26845774
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]